Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

|

October 21st, 2020

Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Conn. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have faced hundreds of lawsuits for the company’s alleged role in the opioid epidemic that has killed more than 200,000 Americans over the past 20 years.

Drew Angerer / Getty Images

Updated at 12:14 p.m. ET

The Justice Department announced on Wednesday a global settlement of civil and criminal investigations into Purdue Pharma’s aggressive marketing of opioid medications, including OxyContin.

Federal officials have long maintained Purdue’s actions helped fuel a prescription opioid epidemic that has killed more than 232,000 Americans, according to the Centers for Disease Control and Prevention.

Related

Top Stories